Deep Tech · Corporate VC · Active
IBM Ventures
IBM Ventures is IBM's corporate venture arm, structured as a $500M Enterprise AI Venture Fund launched in 2024 and now treating quantum computing as strategically co-equal with AI.
Investment thesis
IBM Ventures is IBM's corporate venture arm, structured as a $500M Enterprise AI Venture Fund launched in 2024 and now treating quantum computing as strategically co-equal with AI. Led by Global Head of VC Emily Fontaine, the fund has made 23 investments to date across AI tools, data preparation, quantum error-correction, and cybersecurity.
IBM Ventures' quantum strategy leans toward software and tools that make its own quantum hardware more useful. Portfolio includes Qedma (Israeli error-mitigation, $26M Series A lead July 2025), QunaSys (Japanese quantum chemistry), Strangeworks (quantum developer platform), Quantinuum (spin-out of Honeywell, co-invested via Cambridge Quantum), SQK (medical imaging) and QodeX Quantum (quantum-native AI).
Value-add is singular: access to IBM's 600K+ active users, 280+ Quantum Network partners, and the largest deployed quantum fleet globally, with a public roadmap toward a large-scale fault-tolerant system by 2029.
Differentiated as the only CVC that can simultaneously invest in and co-develop with its portfolio via owned quantum infrastructure.
Anti-thesis
The patterns that trigger a fast no with this fund.
- Hardware companies directly competing with IBM's superconducting modular roadmap are unlikely fits.
Notable quantum portfolio
Full portfolio →Reach out to IBM Ventures
A cold email and a 1-page brief, ready in two clicks.